Received Nov 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | IM |
More frequent macular aura; This spontaneous case was reported by a consumer and describes the occurrence of AURA (More frequent macular aura) in a female patient of an unknown age who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. Previously administered products included for Product used for unknown indication: PFIZER BIONTECH COVID-19 VACCINE (Pfizer had horrid reaction chills, flu, and feverish for at least two days.), PFIZER BIONTECH COVID-19 VACCINE (Pfizer had horrid reaction chills, flu, and feverish for at least two days.), PFIZER BIONTECH COVID-19 VACCINE (Pfizer had horrid reaction chills, flu and and feverish for at least two days.). Past adverse reactions to the above products included Chills with PFIZER BIONTECH COVID-19 VACCINE; Feverish with PFIZER BIONTECH COVID-19 VACCINE; and Flu with PFIZER BIONTECH COVID-19 VACCINE. Concurrent medical conditions included Macular degeneration. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) 1 dosage form. On an unknown date, the patient experienced AURA (More frequent macular aura). At the time of the report, AURA (More frequent macular aura) had resolved. First problem with the Pfizer vaccine reported and then mentioned the Moderna vaccine. Pfizer had horrid reaction chills, flu, and feverish for at least two days. No concomitant medication was reported. From moderna vaccine, patient had more frequent macular aura after the first two or three vaccines. It was unknown if the patient experienced any additional symptoms/events. No treatment medication was reported. Reporter causality was not reported.
Macular degeneration